Day Two, September 5, 2025 - MT (Mexican Pacific Time, GMT-07:00)
- Liz Turner - Vice President, Global Market Access, Mirum Pharmaceuticals, Inc.
After looking ahead, take a step back to hear from key team members as they discuss all things launch prep.
- Highlight hurdles to be weary of and call out key considerations to ensure a seamless product/program introduction to the market
- Run through the journey of building out your program, complete with both operational and compliance perspectives to cover strategy and risk mitigation
- Identify essential elements during the vendor selection and contract negotiation process
- Rakan Ghubej - Senior Director, Senior Corporate Counsel, Kyowa Kirin, Inc.
- Bruce Pfaff - Senior Director, Trade & Distribution, Cytokinetics
- Sheila Bhattacharya - Vice President, Market Access and Strategic Accounts, Azurity Pharmaceuticals
The healthcare policy and drug pricing landscape is undergoing significant disruption, with state-level reforms gaining traction while federal initiatives remain uncertain. At the same time, manufacturers face mounting pricing pressures driven by policies like the IRA and evolving payer dynamics. This session will provide critical insights into policy reform, payer challenges impacting pricing and patient access and strategies manufacturers can adopt to navigate this rapidly shifting environment.
- Adelpha Abrahamson Larkin - Senior Director, Payer and Pricing Strategy, Day One Biopharmaceuticals
Join us for an engaging session that untangles the complexities of today's patient access landscape. In this session, you will:
Analyze Emerging Trends:
Examine the latest industry shifts—from state-level bans to key litigation cases—and assess how these trends are redefining affordability program strategies.Explore Innovative Strategies:
Learn how forward-thinking manufacturers are overcoming the challenges of accumulator and maximizer programs to keep medications affordable for patients.Optimize Financial Management:
Discover best practices for managing gross-to-net budgets to enhance the sustainability and performance of patient access programs under evolving regulatory demands.
- Lisa Kommers - Senior Director, Market Access, Corcept Therapeutics
Hear from the Servier team directly on the ServierONE patient support program, an initiative they are rolling out to appropriately build program awareness in a highly regulated environment. With engagement from internal and external stakeholders, ServierONE has been established as a trusted resource among HCO's, patients and advocacy communities. During this session, uncover the strategies the Servier team has implemented to raise awareness and education of the ServierONE program, how they continue to drive adherence through enhanced communication, lessons learned and their thought process moving forward.
- Naveed Masood - Head, US Patient Services, Servier
As the scope and model surrounding FRMs continues to change, one thing remains constant, and that is the need for FRMs to be aligned across the various patient services teams. During this session, hear how Menarini is innovating in the FRM space to ensure a cohesive and integrated partnership. Understand the importance of having a proactive vs reactive FRM strategy and the data/tools you can give them to be more proactive.
- Jennifer Clark - Senior Director, Patient Services, Stemline Therapeutics
- Donna Parker - Director, Payer & Reimbursement, West Region, Stemline Therapeutics
This exclusive executive luncheon brings together director-level and above Hub West attendees for meaningful dialogue in an intimate setting. Engage with industry peers to exchange leadership insights and develop strategic connections.
**Attendance for this session is limited and RSVP is required. To secure a spot, please email callie.mertel@informa.com. Attendance is at the discretion of Informa Connect – attendees must be at the director level or above.
With an everchanging SP landscape, it’s essential to develop sustainable partnership models between manufacturers and distribution channels to provide the best patient care. During this session, hear how UC Health has created closer coordination between hub programs and SP’s with an omni-channel approach. Hear examples of both successful and more challenging roll-outs and learn best practices in improving partnership with limited resources to keep the patient at the center of focus.
- Kanika Chandra - Director, Systemwide Pharmacy Specialty Operations, University of California Office of the President, UC Health
As the patient services industry becomes increasingly more digital, take a deeper dive into the innovative platforms, tools and strategies that can supercharge your program within the evolving hub model. Hear firsthand experiences on building out digital solutions to optimize the patient journey. As the patient services industry becomes increasingly more digital, take a deeper dive into the innovative platforms, tools and strategies that can supercharge your program within the evolving hub model. Hear firsthand experiences on building out digital solutions to optimize the patient journey.
- Valerie Sullivan - Board Member, Executive Advisor